Pharmaceutical Packaging Market Prospects – Innovations in Packaging and Drug Delivery
.png)
Download the Pharmaceutical Packaging Market Prospects Trend Report to explore the full report and delve into the evolving opportunities in pharmaceutical packaging and drug delivery.
As pharmaceutical companies shift toward more complex and personalised treatments, packaging innovation is becoming a critical factor in drug development. With biologics and targeted therapies gaining prominence, the need for packaging that accommodates unique delivery, storage, and patient usability requirements is accelerating.
Biologics – complex formulations that often require refrigeration and device-based delivery – are driving demand for cold chain-compatible, patient-friendly packaging solutions. Asmita Khanolkar of SMC Ltd. emphasizes the importance of tailored strategies for biologics, especially given the rise of self-administration and smaller patient populations for personalized treatments. Unlike mass-market drugs of the past, today’s therapies must be designed with precision and flexibility in mind.
The popularity of GLP-1 agonists, which are used to treat diabetes and obesity, underscores the growing market for high-value injectables. With forecasts estimating these drugs could generate over $100 billion by 2030, pharmaceutical companies are focusing more on delivery systems like autoinjectors and wearable devices. These solutions enhance ease of use and support home-based care – an increasingly important model as the global population ages.
Beyond biologics, packaging for oral formulations is evolving as well. Modified-release tablets, high-potency APIs, and orphan drugs are spurring demand for protective blister packs and containment solutions that ensure safety and compliance.
Digitisation is also transforming pharmaceutical packaging. AI and machine learning are being used to improve patient adherence through smart packaging, such as connected pill bottles and electronic dose tracking systems. These technologies can also enhance supply chain operations, personalize packaging design, and support sustainability goals by reducing waste and optimising materials.
Looking ahead, investments in advanced formulations – like long-acting injectables, microneedles, and implantable devices – are expected to grow. These innovations demand precise fill-finish technologies and scalable packaging processes. As the pharmaceutical landscape becomes more patient-centric and data-driven, packaging will play a central role in delivering both therapeutic effectiveness and improved user experiences.
In this evolving market, pharmaceutical packaging is no longer an afterthought – it’s a strategic asset that bridges therapy, technology, and patient needs.
Discover the full Pharmaceutical Packaging Market Prospects Trend Report here.
Related News
-
News Women in Pharma: Unlocking patient inclusion at CPHI Americas
Our monthly Women in Pharma series highlights the influential lives and works of impactful women working across the pharmaceutical industry, and how the industry can towards making the healthcare industry and workplace more equitable and inclusive.&nbs... -
News Tracking Innovation with Thermo Fisher Scientific: CPHI Americas Track Sponsor interview
As we gear up for CPHI Americas from May 20-22, 2025 at the Philadelphia Convention Center, we sat down with Track Sponsor Thermo Fisher Scientific to discuss the future of bioproduction in pharma.
-
News Welcome back to the CPHI Exhibitor Spotlight!
We’re continuing our journey through the standout companies heading to CPHI Americas 2025, and next up is Adare - a global leader known for turning complex formulation challenges into innovative, patient-centric solutions.
-
News PhRMA trade association issues comments on Section 232 investigation
The Pharmaceutical Research and Manufacturers of America (PhRMA), an American trade association representing groups in the pharmaceutical industry, issued a letter on May 6, 2026 to the Department of Commerce regarding the Section 232 National Security... -
News Pharmaceutical Packaging Market Prospects: Shifting regional policies
The pharmaceutical packaging industry is experiencing significant transformation in 2025, driven by regulatory changes, supply chain challenges, and sustainability initiatives. The US BIOSECURE Act, passed through the House of Representatives in Septem... -
News Executive order to elevate US pharma manufacturing signed by Trump
On Monday, May 5, US President Trump signed an executive order to reduce regulatory barriers for domestic US pharmaceutical manufacturing, including key ingredients and materials for manufacturing prescription drugs.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News China import tax fine could cost AstraZeneca up to US$8 million
British-Swedish drugmaker AstraZeneca could find itself facing fines of up to US$8million in China due to suspected unpaid import taxes on breast cancer drug Enhertu.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance